In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
The World Health Organization has revised its guidelines to say that every person infected with HIV should now be given powerful anti-AIDS drugs.... World Health Organization Posts Ambitious New ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
June 21 (UPI) --The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States plans to phase them out next year ...
Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...
The recommended change would mean that patients would begin treatment before they get extremely sick. In Africa, where millions of people are... South Africa Weighs Starting HIV Drug Treatment Sooner ...
Summary Box: CDC recommends HIV drug treatment for all people exposed to virusWith BC-HIV Guidelines, BjtCHANGING PRACTICES: The government recommended for the first time that rape victims and certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback